Martin Hosking, PhD
Director of Research & Development
Fate Therapeutics
San Diego
iSPC-Derived CAR T Cell Therapy for the Treatment of Cancer and Autoimmunity
Thursday, January 22nd
12:00 PM
In-person seminar
Thorp Conference Center, Gross Hall 4th Floor
ALL IMMUNOLOGY GRAD STUDENTS ARE EXPECTED TO ATTEND